Table 1. Patient characteristics and... | American Society of Hematology

Table 1.

Patient characteristics and treatment

Patients

No. (hemophilia A, B)

(66, 10)

Age at last Pettersson evaluation, y

19.0

(14.7-25.0)

Age at first joint bleed, y

2.2

(1.2-3.0)

Treatment

Age at first treatment, y

1.2

(0.7-1.7)

Age at start of prophylaxis, y

6.3

(4.0-8.9)

Lag time (first joint bleed until start of prophylaxis), y

3.3

(1.4-6.1)

No. of joint bleeds before start of prophylaxis

(5-44)

Duration of prophylactic treatment, y

12.5

(8.0-18.2)

Weekly dose of prophylaxis, IU/kg/wk^*

(25-39)

Annual clotting factor use, IU/kg/y^*

1750

(1462-2191)

Values are numbers or medians (numbers or IQR: 25th and 75th percentiles).

For all years on prophylactic treatment.